Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Sandrine, Huclier-Markai

  • Google
  • 2
  • 6
  • 0

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (2/2 displayed)

  • 2021Flow Field-Flow fractionation for an accurate characterization of polysaccharides  citations
  • 2018Anti-metastatic properties of marine exopolysaccharide complexes for bone oncology applications and morecitations

Places of action

Chart of shared publication
Cyrille, Alliot
2 / 2 shared
Sinquin, Corinne
2 / 8 shared
Colliec-Jouault, Sylvia
2 / 7 shared
Pascal, Rellier
1 / 1 shared
Mattia, Mazza
1 / 1 shared
Elodie, Mounier
1 / 1 shared
Chart of publication period
2021
2018

Co-Authors (by relevance)

  • Cyrille, Alliot
  • Sinquin, Corinne
  • Colliec-Jouault, Sylvia
  • Pascal, Rellier
  • Mattia, Mazza
  • Elodie, Mounier
OrganizationsLocationPeople

document

Anti-metastatic properties of marine exopolysaccharide complexes for bone oncology applications and more

  • Pascal, Rellier
  • Cyrille, Alliot
  • Sandrine, Huclier-Markai
  • Sinquin, Corinne
  • Mattia, Mazza
  • Colliec-Jouault, Sylvia
  • Elodie, Mounier
Abstract

The anti-metastatic properties of an exopolysaccharide (EPS) derivative produced by a deep-sea hydrothermal bacterium, were favorably evaluated on bone remodeling. This polysaccharide called GY785 is excreted outside the cell during fermentation by the bacterial strain Alteromonas infernus. The native EPS, with a high-molecular-weight (106 g/mol, 10% sulfate content) is then chemically modified by depolymerization and oversulfatation to obtain low-molecular-weight derivatives called GY785DR and GY785DRS (24-35.103 g/mol, sulfate content 20 to 40%). These modified EPS have anticoagulant properties and inhibit cancer metastasis. Heparin is currently used in therapy; the purpose of these derivatives could be an alternative use for some therapeutic indications. The coupling of this molecule with radionuclides, could pave the way to new therapeutic uses. The goal of this work is to scrutinize the feasibility of such coupling. Among the theranostic tracers available, scandium is of interest. 44Sc (β+, T1/2=3.97 h) for diagnostics / 47Sc (β-,γ, T1/2=3.351 d) for therapy, is a valuable alternative to 68Ga or 64Cu for PET-imaging of cancer prior to 177Lu- or 90Y-based radionuclide therapy. When 68Ga or 111In are used for pre-therapeutic imaging, for therapeutic radionuclides such as 90Y or 177Lu, different in vivo uptake especially in critical organs such as bone and liver is observed due to dissimilar coordination chemistry, thus not truly reflecting the pharmacokinetic parameters of the therapeutic agent. Moreover 44Sc has an isomeric state, 44mSc (T1/2=58.6h), co-produced with 44Sc that can be used as an in vivo 44mSc/44Sc generator allowing to study pharmacokinetics by PET imaging up to 47Sc comparable times for optimal dosimetry. The stability constants between these EPS with scandium have been studied. Potentiometric titration is not the most suitable technique to visualize the complexation because the stability of this sulphated EPS is limited to a short pH range. A different analytical technique was necessary. The complexation has been assessed from a molecular point of view through Time-Resolved Laser-Induced Fluorescence Spectroscopy (TRLIFS), using Eu to mimic scandium. TRLIFS measurements were conducted on europium with both ligands, heparin and EPS, and their isotherms have shown that complexation definitely occurs for stoichiometric ratio M:L of 1:1 and it could also occur for 1:10 ratio.

Topics
  • impedance spectroscopy
  • titration
  • fluorescence spectroscopy
  • Scandium
  • dosimetry
  • fermentation
  • Europium